MarginsXMarginsX
Home › Markets › Health Care › VVOS

Vivos Therapeutics Inc. (VVOS)

VVOS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.0822
-16.12% on the day
Market cap
$2.8M
Nano cap
Revenue · 2025
$17.4M
+16.0% on 2024
Net income · 2025
-$21.2M
-121.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1716166/000149315226016854/0001493152-26-016854-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerVVOS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2020
SEC CIK0001716166
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$17.4M
Net income-$21.2M
Operating income-$19.9M
Net margin-121.4%
Operating margin-114.1%
Revenue growth+16.0%
Cash$2.0M
Total assets$25.2M
P/E (computed)Net income was not positive
P/S (computed)0.2×

Warning signs

Cash runway
1.2 months
$1.8M cash at June 30, 2026
Share count, 1 year
+168.1%
2025-08-18 to 2026-08-13 · +1580.5% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern."
10-Q 2026-08-14
Cash and burn$1.8M cash; operating cash flow -$4.3M a quarter.Report 2026-06-30
Shares outstanding20,118,023 (2026-08-13); 7,504,807 a year earlier; 29,928,786 three years earlier. 3y figure adjusted for split (1-for-25 overall).Cover page 2026-08-13
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-02-17
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-06-08
AuditorBaker Tilly US, LLP, Denver, Colorado, United States; changed auditors 2 times in 24 months8-K 4.01 2026-10-01
Late filings, 12 months2 NT noticesNT 10-Q 2026-05-15
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 33,609,398 shares at the 2026-11-13 price; the latest SEC cover count is 20,118,023 as of 2026-08-13. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$5.2M-$5.5M-$3.1M$1.8M$582K$20.9M10-Q 2026-08-14
Q1 2026
2026-03-31
$5.1M-$7.7M-$6.0M$2.1M$617K$19.6M10-Q 2026-05-20
Q4 2025
2025-12-31
$3.8M-$6.9M-$3.8M$2.0M$727K$17.4M10-K 2026-04-15
Q3 2025
2025-09-30
$6.8M-$5.4M-$4.2M$3.1M$8.7M$17.3M10-Q 2025-11-19
Q2 2025
2025-06-30
$3.8M-$5.0M-$3.5M$4.4M$7.9M$14.4M10-Q 2026-08-14
Q1 2025
2025-03-31
$3.0M-$3.9M-$3.8M$2.3MNo debt tags$14.6M10-Q 2026-05-20
Q4 2024
2024-12-31
$3.7M-$2.8M-$2.9M$6.3M$1.2M$15.0M10-K 2026-04-15
Q3 2024
2024-09-30
$3.9M-$2.6M-$4.2M$6.3M$1.2M$14.6M10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-05-08
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-10-21
Latest proxyDEFA14A2026-11-02

Source: SEC EDGAR submissions feed, 302 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.3%
1 month-31.0%
3 months-67.9%
Year to date-95.2%
1 year-96.0%
From 52-week high-96.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
IVFINVO Fertility Inc.$2.40-7.69%$2.8M
ICCMIceCure Medical Ltd.$0.7601+4.12%$2.6M
BJDXBluejay Diagnostics Inc.$2.29-12.26%$2.6M
CODXCo-Diagnostics Inc.$0.2249-13.03%$2.4M
XAIRBeyond Air Inc.$2.02-5.16%$3.4M
AMIXAutonomix Medical Inc.$1.10-19.71%$2.2M
TNONTenon Medical Inc.$1.33-5.32%$3.6M
NXGLNexGel Inc$3.93+2.08%$1.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier